Phosphoinositide 3-kinase-gamma expression is upregulated in brain microglia and contributes to ischemia-induced

Rong Jin1, Shiyong Yu, Zifang Song

  • 1Department of Neurosurgery, Vascular Biology & Stroke Research Laboratory, Louisiana State University Health Sciences Center, Shreveport, LA, USA.

Insights

Phosphoinositide 3-kinase gamma (PI3Kgamma) drives microglial activation and expansion after ischemic stroke. Inhibiting PI3Kgamma may offer a neuroprotective strategy by reducing brain damage and cell death.

Area of Science:

  • Neuroscience
  • Immunology
  • Molecular Biology

Background:

  • Microglia, the brain's immune cells, activate rapidly after ischemic stroke.
  • Understanding microglial activation mechanisms is crucial for developing neuroprotective therapies.
  • Microglial activation inhibition may mitigate blood-brain barrier damage and neuronal apoptosis post-stroke.

Purpose of the Study:

  • To investigate the role of Phosphoinositide 3-kinase gamma (PI3Kgamma) in microglial activation following ischemic stroke.
  • To determine the expression patterns of PI3Kgamma in normal and ischemic brain tissue.
  • To elucidate the contribution of PI3Kgamma to ischemia-induced microglial responses.

Main Methods:

  • Examined PI3Kgamma mRNA and protein expression in normal and post-ischemic mouse brains.
  • Utilized mouse brain endothelial and microglial cell lines for in vitro studies.
  • Compared microglial activation and expansion in PI3Kgamma knockout mice versus wild-type mice after induced ischemia.

Main Results:

  • PI3Kgamma is constitutively expressed in normal brain microvessels and significantly upregulated in activated microglia post-ischemia.
  • PI3Kgamma expression was confirmed in mouse brain endothelial and microglial cell lines.
  • Absence of PI3Kgamma in knockout mice markedly reduced early microglial activation and subsequent expansion.

Conclusions:

  • PI3Kgamma is an ischemia-responsive gene in brain microglia.
  • PI3Kgamma plays a critical role in mediating ischemia-induced microglial activation and expansion.
  • Targeting PI3Kgamma presents a potential therapeutic avenue for stroke treatment.